Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID-19 HEART unveiling as atrial fibrillation: pathophysiology, management and future directions for research
Sri Harsha Kanuri, Prapthi Jayesh Sirrkay, Ayse Sena Ulucay
The Egyptian Heart Journal (2023) Vol. 75, Iss. 1
Open Access | Times Cited: 11

Showing 11 citing articles:

Fibrinaloid Microclots and Atrial Fibrillation
Douglas B. Kell, Gregory Y.H. Lip, Etheresia Pretorius
Biomedicines (2024) Vol. 12, Iss. 4, pp. 891-891
Open Access | Times Cited: 5
Effects of dietary approaches to prevent hypertension and enhance cardiovascular health
Arumugam Vignesh, Thomas Cheeran Amal, A. Shanmugam, et al.
Discover Food (2025) Vol. 5, Iss. 1
Open Access
Exploring Serum and Glucocorticoid-Regulated Kinase 1: A Promising Target for COVID-19 and Atrial Fibrillation Treatment
J. Fatima, Faez Iqbal Khan, Jamal e Fatima
Heart Rhythm O2 (2025)
Open Access
Impact of COVID-19 pandemic on the prescribing pattern of oral anticoagulants in the English primary care setting: a population-based segmented interrupted time series analysis of over 53 million individuals
Amanj Kurdi, Abdulaziz Albutti, Omeed Darweesh, et al.
Expert Review of Clinical Pharmacology (2025)
Closed Access
Three decades of atrial fibrillation and flutter epidemiology and risk factors in Iran with a focus on the impact of COVID-19
Hoomaan Ghasemi, Mohammad-Mahdi Bastan, Morvarid Najafi, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
The cardiovascular effects of interleukin-6 inhibition in patients with severe coronavirus-19 infection
Michael Binder, Clinton Timmerman, Biwar Z. Marof, et al.
Journal of International Medical Research (2025) Vol. 53, Iss. 4
Open Access
COVID-19 pandemic and initiation of treatment for atrial fibrillation: a nationwide analysis of claims data
Lanting Yang, Shangbin Tang, Meiqi He, et al.
BMC Cardiovascular Disorders (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 4
Unlocking the therapeutic potential of edible mushrooms: Ganoderma and their secondary metabolites as novel antiviral agents for combating COVID-19
Samantha C. Karunarathna, Wenhua Lu, Nimesha Patabedige, et al.
New Zealand Journal of Botany (2024), pp. 1-59
Closed Access | Times Cited: 1
Cardiovascular comorbidities and COVID-19 outcomes
Fabián Sanchis‐Gomar, Giuseppe Lippi, Carl J. Lavie, et al.
Elsevier eBooks (2024), pp. 19-26
Closed Access
Staged hybrid ablation in left atrial appendage aneurysm a rare cause of refractory atrial tachyarrhythmia - a case report
A Mittal, Manoraj Navaratnarajah, Stephen Harden, et al.
European Heart Journal - Case Reports (2024) Vol. 8, Iss. 7
Open Access
Features of the Course of Atrial Fibrillation in Patients with the History of COVID-19: Impact on the Possibility and Tactics of Restoring Sinus Rhythm
O. V. Stasyshena, O. S. Sychov
Ukrainian journal of cardiovascular surgery (2023) Vol. 31, Iss. 3, pp. 87-92
Open Access
Page 1

Scroll to top